STOCK TITAN

CTS Corp SEC Filings

CTS NYSE

Welcome to our dedicated page for CTS SEC filings (Ticker: CTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking how piezoelectric sensors and actuators move CTS Corporation’s revenue needle means diving into hundreds of technical pages. Whether you’re comparing defense contracts with medical-device demand or gauging foreign-exchange exposure, the data hides deep inside forms most investors skim. CTS Corporation SEC filings explained simply is exactly what busy analysts need—and exactly what Stock Titan delivers.

Our platform’s AI reads every submission the moment it hits EDGAR, so understanding CTS Corporation SEC documents with AI takes minutes, not afternoons. Need the latest CTS Corporation quarterly earnings report 10-Q filing? It’s condensed with revenue by end-market and margin drivers. Want immediate alerts on insider activity? CTS Corporation Form 4 insider transactions real-time appear in your dashboard as they post. The same engine decodes cash-flow tables, segment notes, and risk factors, turning them into clear CTS Corporation earnings report filing analysis.

Below are quick links to the disclosures investors search for most:

  • CTS Corporation annual report 10-K simplified for full-year strategy signals
  • CTS Corporation insider trading Form 4 transactions and CTS Corporation executive stock transactions Form 4 to spot buying or selling trends
  • CTS Corporation proxy statement executive compensation to benchmark leadership incentives
  • CTS Corporation 8-K material events explained for sudden contract wins or leadership changes

Every filing—from S-8 share plans to credit-agreement exhibits—arrives with real-time updates, AI-powered summaries, and expert context. Stock Titan transforms dense disclosures into actionable clarity, so you can act on sensor-segment metrics or insider trades before the market does.

Rhea-AI Summary

CTS Corporation (NYSE: CTS) reported Q3 2025 results. Net sales were $142.97M, up from $132.38M a year ago, driven by Industrial ($37.10M vs $30.75M), Medical ($21.96M vs $18.02M), and Aerospace & Defense ($25.36M vs $20.59M), while Transportation softened ($58.55M vs $63.03M). Operating earnings were essentially flat at $20.94M. Net earnings were $13.69M vs $18.08M, with diluted EPS of $0.46 vs $0.59 as higher SG&A and R&D offset gross profit gains.

Year to date, sales reached $404.05M vs $388.30M and net earnings were $45.58M vs $43.91M (diluted EPS $1.52 vs $1.43). Cash provided by operations was $72.89M, ending cash was $110.30M, and long‑term debt was $90.70M (weighted average rate 5.56%). The company repurchased 399,500 shares for $16.74M in Q3 and $40.08M year to date, with approximately $21.34M remaining under its program. Remediation reserves increased to $15.90M; for the Asheville, NC matter, the company recorded a $5.97M loss estimate within an updated exposure range of $5.97M to $8.29M. Shares outstanding were 29,052,423 as of October 21, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
quarterly report
-
Rhea-AI Summary

CTS Corporation furnished an investor presentation under Item 7.01 (Regulation FD) in a Form 8‑K. The presentation, included as Exhibit 99.1 and dated October 2025, may be used in meetings with investors and analysts during the fiscal year ended December 31, 2025. The company states the materials are furnished, not filed, and are not subject to Section 18 liability or incorporated by reference unless specifically referenced.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
current report
-
Rhea-AI Summary

CTS Corporation furnished an update on its business by providing a press release with certain results for the third quarter ended September 30, 2025, and related presentation materials. The company also announced a live webcast on October 28, 2025 to discuss these results.

The materials are furnished under Items 2.02 and 7.01 and are not deemed filed under the Exchange Act. Attached exhibits include the earnings release (Exhibit 99.1), the Q3 2025 slide deck (Exhibit 99.2), and the cover page interactive data file (Exhibit 104).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
current report
Rhea-AI Summary

BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of CTS CORP common stock. BlackRock reports 4,334,951 shares beneficially owned, representing 14.7% of the class as of the event date 09/30/2025.

BlackRock has sole voting power over 4,265,805 shares and sole dispositive power over 4,334,951 shares, with no shared voting or dispositive power. The filing states the securities are held in the ordinary course and not for the purpose of changing or influencing control. The filing also notes that iShares Core S&P Small-Cap ETF has an interest of more than five percent of CTS CORP’s outstanding common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

EARNEST Partners, LLC reports beneficial ownership of 1,976,058 shares of CTS Corp common stock, representing 6.7% of the class as of the reported event. The filing shows EARNEST holds sole dispositive power over all 1,976,058 shares and sole voting power over 1,337,689 shares, with shared voting power for 188,130 shares. The firm is filing as an investment adviser and states that no single client account holds more than 5% of the class. The filing includes a certification that the shares were acquired in the ordinary course of business and are not intended to influence control of the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

CTS Corporation (CTS) filed a Form 4 showing that Chief Legal & Administrative Officer Mark R. Pacioni received 4,600 restricted stock units (RSUs) on 07/29/2025. The award is coded “A” (grant) and carries a cash price of $0, indicating it is part of routine equity compensation rather than an open-market purchase. According to the footnote, the RSUs vest one-third annually. After the grant, Pacioni’s direct beneficial ownership totals 4,600 CTS common shares; no derivative securities were reported. The transaction is small relative to CTS’s share count and does not signal any change in strategic outlook or provide new financial information. Overall, this is a standard insider equity award with negligible impact on the company’s capital structure or valuation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.86%
Tags
quarterly report
-
Rhea-AI Summary

CTS Corporation filed a Form 8-K dated 24 July 2025 under Item 7.01 (Reg FD). The filing furnishes, but does not file, an investor presentation (Exhibit 99.1) that may be used in meetings with investors and analysts during fiscal-year 2025. Management explicitly disclaims that the furnished material should be deemed “filed” for Exchange Act liability or incorporated by reference into other SEC filings. No financial results, transaction details, or strategic announcements are included. Exhibit 104 covers the Inline XBRL cover-page data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.86%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.86%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of CTS (CTS)?

The current stock price of CTS (CTS) is $42.87 as of January 1, 2026.

What is the market cap of CTS (CTS)?

The market cap of CTS (CTS) is approximately 1.2B.
CTS Corp

NYSE:CTS

CTS Rankings

CTS Stock Data

1.25B
28.39M
2.15%
97.03%
0.97%
Electronic Components
Printed Circuit Boards
Link
United States
LISLE